4.4 Article

Free-living monitoring of ambulatory activity after treatments for lower extremity musculoskeletal cancers using an accelerometer-based wearable - a new paradigm to outcome assessment in musculoskeletal oncology?

Journal

DISABILITY AND REHABILITATION
Volume 45, Issue 12, Pages 2021-2030

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09638288.2022.2083701

Keywords

Functional outcomes; sarcoma; cancer; quality of life; rehabilitation; ambulatory activity; ambulation; mobility

Categories

Ask authors/readers for more resources

This study assessed the ambulatory activity of patients with musculoskeletal tumors using a wearable AX3 device. The results showed that the AX3 device could effectively evaluate volume, pattern, and variability of walking after sarcoma surgery, providing valuable information about patients' physical performance at home, which can guide rehabilitation.
Purpose Ambulatory activity (walking) is affected after sarcoma surgery yet is not routinely assessed. Small inexpensive accelerometers could bridge the gap. Study objectives investigated, whether in patients with lower extremity musculoskeletal tumours: (A) it was feasible to conduct ambulatory activity assessments in patient's homes using an accelerometer-based wearable (AX3, Axivity). (B) AX3 assessments produced clinically useful data, distinguished tumour sub-groups and related to existing measures. Methods In a prospective cross-sectional pilot, 34 patients with musculoskeletal tumours in the femur/thigh (19), pelvis/hip (3), tibia/leg (9), or ankle/foot (3) participated. Twenty-seven had limb-sparing surgery and seven amputation. Patients were assessed using a thigh-worn monitor. Summary measures of volume (total steps/day, total ambulatory bouts/day, mean bout length), pattern (alpha), and variability (S-2) of ambulatory activity were derived. Results AX3 was well-tolerated and feasible to use. Outcomes compared to literature but did not distinguish tumour sub-groups. Alpha negatively correlated with disability (walking outside (r=-418, p = 0.042*), social life (r=-0.512, p = 0.010*)). Disability negatively predicted alpha (unstandardised co-efficient= -0.001, R-2=0.186, p = 0.039*). Conclusions A wearable can assess novel attributes of walking; volume, pattern, and variability after sarcoma surgery. Such outcomes provide valuable information about people's physical performance in their homes, which can guide rehabilitation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available